T1	PROC 1 29	Intervenciones farmacéuticas
#1	AnnotatorNotes T1	C1135470; Pharmaceutical procedures and interventions; Therapeutic or Preventive Procedure
T2	DISO 47 71	Diabetes Mellitus Tipo 2
#2	AnnotatorNotes T2	C0011860; Diabetes Mellitus, Non-Insulin-Dependent; Disease or Syndrome
T3	PROC 93 114	Atención Farmacéutica
#3	AnnotatorNotes T3	C0031321; Pharmaceutical Services; Health Care Activity
T4	PROC 149 163	farmacoterapia
#4	AnnotatorNotes T4	C0013216; Pharmacotherapy; Therapeutic or Preventive Procedure
T5	PROC 301 329	intervenciones farmacéuticas
#5	AnnotatorNotes T5	C1135470; Pharmaceutical procedures and interventions; Therapeutic or Preventive Procedure
T6	DISO 347 371	Diabetes Mellitus Tipo 2
#6	AnnotatorNotes T6	C0011860; Diabetes Mellitus, Non-Insulin-Dependent; Disease or Syndrome
T7	PROC 532 543	intervenido
#7	AnnotatorNotes T7	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T8	PROC 581 592	entrevistas
#8	AnnotatorNotes T8	C0683518; patient interview; Health Care Activity
T9	PROC 620 645	intervención farmacéutica
#9	AnnotatorNotes T9	C1135470; Pharmaceutical procedures and interventions; Therapeutic or Preventive Procedure
T10	PROC 812 823	intervenido
#10	AnnotatorNotes T10	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T11	PROC 907 930	hemoglobina glicosilada
#11	AnnotatorNotes T11	C0202054; Glucohemoglobin measurement; Laboratory Procedure
T12	PROC 1128 1139	intervenido
#12	AnnotatorNotes T12	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T13	DISO 1158 1197	problemas relacionados con medicamentos
T14	CHEM 1185 1197	medicamentos
#13	AnnotatorNotes T14	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T15	PROC 1595 1603	glicemia
#14	AnnotatorNotes T15	C0392201; Blood glucose measurement; Laboratory Procedure
T16	DISO 1291 1330	problemas relacionados con medicamentos
T17	CHEM 1318 1330	medicamentos
#15	AnnotatorNotes T17	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T18	PROC 1350 1378	intervenciones farmacéuticas
#16	AnnotatorNotes T18	C1135470; Pharmaceutical procedures and interventions; Therapeutic or Preventive Procedure
T19	DISO 1431 1441	enfermedad
#17	AnnotatorNotes T19	C0012634; Disease; Disease or Syndrome
T20	CHEM 1483 1495	medicamentos
#18	AnnotatorNotes T20	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T21	PROC 1529 1557	intervenciones farmacéuticas
#19	AnnotatorNotes T21	C1135470; Pharmaceutical procedures and interventions; Therapeutic or Preventive Procedure
T22	PROC 1605 1628	hemoglobina glicosilada
#20	AnnotatorNotes T22	C0202054; Glucohemoglobin measurement; Laboratory Procedure
T23	CHEM 1652 1664	medicamentos
#21	AnnotatorNotes T23	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T24	DISO 1683 1722	problemas relacionados con medicamentos
T25	CHEM 1710 1722	medicamentos
#22	AnnotatorNotes T25	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T26	PROC 421 442	medición de variables
T27	PROC 388 415	Ensayo Clínico Aleatorizado
#23	AnnotatorNotes T27	C0206034; Clinical Trials, Randomized; Research Activity
T28	CHEM 907 918	hemoglobina
#24	AnnotatorNotes T28	C0019046; Hemoglobin; Amino Acid, Peptide, or Protein · Biologically Active Substance
T29	CHEM 1605 1616	hemoglobina
#25	AnnotatorNotes T29	C0019046; Hemoglobin; Amino Acid, Peptide, or Protein · Biologically Active Substance
T30	PROC 837 845	glicemia
#26	AnnotatorNotes T30	C0392201; Blood glucose measurement; Laboratory Procedure
T31	PROC 1081 1113	medido con el cuestionario SF-36
#27	AnnotatorNotes T31	C4749356; Assessment using MOS SF-36 (Medical Outcomes Study 36-Item Short Form Health Survey); Health Care Activity
T33	LIVB 33 42	pacientes
#28	AnnotatorNotes T33	C0030705; Patients; Patient or Disabled Group
T35	LIVB 252 261	pacientes
#29	AnnotatorNotes T35	C0030705; Patients; Patient or Disabled Group
T37	LIVB 333 342	pacientes
#30	AnnotatorNotes T37	C0030705; Patients; Patient or Disabled Group
T39	LIVB 512 521	pacientes
#31	AnnotatorNotes T39	C0030705; Patients; Patient or Disabled Group
T40	LIVB 552 565	grupo control
#32	AnnotatorNotes T40	C0009932; Control Groups; Group
T41	Frequency 593 602	mensuales
T43	Duration 649 656	6 meses
T44	Date 664 676	octubre 2011
T45	Date 683 693	junio 2012
T46	LIVB 758 767	pacientes
#33	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group
T47	Age 772 786	55,6±10,6 años
T48	LIVB 792 801	pacientes
#34	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group
T49	LIVB 863 872	pacientes
#35	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T51	LIVB 953 962	pacientes
#36	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T52	LIVB 1205 1214	pacientes
#37	AnnotatorNotes T52	C0030705; Patients; Patient or Disabled Group
T53	LIVB 1259 1268	pacientes
#38	AnnotatorNotes T53	C0030705; Patients; Patient or Disabled Group
T55	LIVB 1412 1421	pacientes
#39	AnnotatorNotes T55	C0030705; Patients; Patient or Disabled Group
T57	LIVB 1760 1769	pacientes
#40	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T32	LIVB 1029 1047	grupo inter-venido
#41	AnnotatorNotes T32	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T34	LIVB 1122 1139	grupo intervenido
#42	AnnotatorNotes T34	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T36	LIVB 806 823	grupo intervenido
#43	AnnotatorNotes T36	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T38	LIVB 526 543	grupo intervenido
#44	AnnotatorNotes T38	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
R1	Experiences Arg1:T33 Arg2:T2	
T42	PROC 229 244	calidad de vida
#45	AnnotatorNotes T42	C0281588; Assessment of quality of life; Diagnostic Procedure
R2	Experiences Arg1:T35 Arg2:T4	
R3	Experiences Arg1:T35 Arg2:T3	
T50	Observation 218 244	mejoren la calidad de vida
#46	AnnotatorNotes T50	C2015892; outcomes general quality of life improved; Finding
R4	Experiences Arg1:T35 Arg2:T50	
R5	Causes Arg1:T3 Arg2:T50	
R6	Experiences Arg1:T37 Arg2:T5	
R7	Experiences Arg1:T37 Arg2:T6	
R8	Before Arg1:T26 Arg2:T27	
R9	After Arg1:T26 Arg2:T27	
T54	Quantifier_or_Qualifier 463 477	probabilístico
A1	Assertion T54 Negated
T56	Neg_cue 460 462	No
R10	Negation Arg1:T56 Arg2:T54	
R11	Experiences Arg1:T38 Arg2:T7	
R12	Experiences Arg1:T39 Arg2:T7	
R13	Has_Frequency Arg1:T8 Arg2:T41	
R14	Has_Duration_or_Interval Arg1:T9 Arg2:T43	
R16	After Arg1:T9 Arg2:T44	
R17	Before Arg1:T9 Arg2:T45	
T58	Observation 718 727	abandonos
#47	AnnotatorNotes T58	C0422727; Patient withdrawn from trial; Finding (?)
R18	Has_Age Arg1:T46 Arg2:T47	
R19	Experiences Arg1:T36 Arg2:T10	
R20	Experiences Arg1:T48 Arg2:T10	
R21	Experiences Arg1:T48 Arg2:T30	
R23	Experiences Arg1:T36 Arg2:T30	
R24	Experiences Arg1:T49 Arg2:T30	
R25	Experiences Arg1:T49 Arg2:T10	
R26	Experiences Arg1:T51 Arg2:T11	
T59	PROC 1009 1024	calidad de vida
#48	AnnotatorNotes T59	C0281588; Assessment of quality of life; Diagnostic Procedure
R27	Experiences Arg1:T32 Arg2:T59	
R28	Experiences Arg1:T35 Arg2:T42	
T60	Observation 1009 1024;1048 1055	calidad de vida aumentó
#49	AnnotatorNotes T60	C2015892; outcomes general quality of life improved; Finding
R29	Experiences Arg1:T32 Arg2:T60	
R30	Experiences Arg1:T48 Arg2:T11	
R31	Experiences Arg1:T36 Arg2:T11	
R32	Experiences Arg1:T49 Arg2:T11	
R33	Experiences Arg1:T34 Arg2:T13	
R34	Causes Arg1:T14 Arg2:T13	
R35	Experiences Arg1:T34 Arg2:T12	
R36	Experiences Arg1:T52 Arg2:T13	
R37	Experiences Arg1:T52 Arg2:T12	
T61	CONC 1238 1255	final del estudio
#50	AnnotatorNotes T61	C2983670; Study End Date; Temporal Concept
R40	Causes Arg1:T17 Arg2:T16	
R41	Experiences Arg1:T55 Arg2:T19	
R48	Causes Arg1:T25 Arg2:T24	
R49	Experiences Arg1:T57 Arg2:T24	
R50	Experiences Arg1:T57 Arg2:T23	
R51	Experiences Arg1:T57 Arg2:T22	
R52	Experiences Arg1:T57 Arg2:T15	
T64	PROC 1737 1752	calidad de vida
#51	AnnotatorNotes T64	C0281588; Assessment of quality of life; Diagnostic Procedure
R53	Experiences Arg1:T57 Arg2:T64	
T65	Observation 1724 1752	mejoraron la calidad de vida
#52	AnnotatorNotes T65	C2015892; outcomes general quality of life improved; Finding
R54	Experiences Arg1:T57 Arg2:T65	
R38	Overlap Arg1:T16 Arg2:T61	
R39	Experiences Arg1:T53 Arg2:T16	
T62	Observation 1383 1404;1422 1441	nivel de conocimiento sobre la enfermedad
#53	AnnotatorNotes T62	C0517724; Knowledge level: disease process; Finding (?)
T63	Observation 1460 1495	conocimiento sobre sus medicamentos
#54	AnnotatorNotes T63	C0517785; Knowledge of Medication; Finding
R55	Experiences Arg1:T55 Arg2:T63	
T66	Quantifier_or_Qualifier 479 494	De conveniencia
T67	CONC 1095 1113	cuestionario SF-36
#55	AnnotatorNotes T67	C1519136; SF-36; Intellectual Product
R57	Used_for Arg1:T67 Arg2:T31	
R58	Used_for Arg1:T67 Arg2:T59	
T68	CONC 1572 1591	parámetros clínicos
R60	Causes Arg1:T21 Arg2:T65	
#56	AnnotatorNotes T13	C0277579; drug-related disorder; Disease or Syndrome (?)
#57	AnnotatorNotes T16	C0277579; drug-related disorder; Disease or Syndrome (?)
#58	AnnotatorNotes T24	C0277579; drug-related disorder; Disease or Syndrome (?)
A2	Experiencer T33 Patient
A3	Experiencer T35 Patient
A4	Experiencer T37 Patient
A5	Experiencer T39 Patient
A6	Experiencer T38 Patient
A7	Experiencer T40 Patient
A8	Experiencer T46 Patient
A9	Experiencer T48 Patient
A10	Experiencer T36 Patient
A11	Experiencer T49 Patient
A12	Experiencer T51 Patient
A13	Experiencer T32 Patient
A14	Experiencer T34 Patient
A15	Experiencer T52 Patient
A16	Experiencer T53 Patient
A17	Experiencer T55 Patient
A18	Experiencer T57 Patient
R15	Has_Result_or_Value Arg1:T64 Arg2:T65	
R22	Has_Result_or_Value Arg1:T42 Arg2:T50	
R42	Has_Result_or_Value Arg1:T59 Arg2:T60	
